Kristina M. Fetalvero

Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer

Meredith S. Eno, Jason D. Brubaker, John E. Campbell et al. · Journal of Medicinal Chemistry · 2022 · 160 citations · Full text

Medicine, Oncology, Pharmacology +14

Rapamycin Promotes Vascular Smooth Muscle Cell Differentiation through Insulin Receptor Substrate-1/Phosphatidylinositol 3-Kinase/Akt2 Feedback Signaling

Kathleen A. Martin, Bethany L. Merenick, Min Ding et al. · Journal of Biological Chemistry · 2007 · 148 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16

Acceleration of Cardiovascular Disease by a Dysfunctional Prostacyclin Receptor Mutation

Eric Arehart, Jeremiah Stitham, Folkert W. Asselbergs et al. · Circulation Research · 2008 · 123 citations · Full text

Medicine, Cardiology, Pharmacology +17

Defective Autophagy and mTORC1 Signaling in Myotubularin Null Mice

Kristina M. Fetalvero, Yenyen Yu, Margaret Goetschkes et al. · Molecular and Cellular Biology · 2012 · 92 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway

Kristina M. Fetalvero, Maureen Shyu, Athena P. Nomikos et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2006 · 75 citations

Medicine, Cardiology, Pharmacology +13